Insider Trading Activity Agile Therapeutics, Inc. (NASDAQ:AGRX) – Chairman Bought 10,000 shares of Stock

ME Staff
-
0

Insider Trading Activity For Agile Therapeutics, Inc. (NASDAQ:AGRX)

Alfred Altomari , Chairman of Agile Therapeutics, Inc. (NASDAQ:AGRX) reportedly Bought 10,000 shares of the company’s stock at an average price of 3.34 for a total transaction amount of $33,400.00 SEC Form

Insider Trading History For Agile Therapeutics, Inc. (NASDAQ:AGRX)

  • On 5/22/2014 Ab Investor, Major Shareholder, bought 1,000,000 with an average share price of $6.00 per share and the total transaction amounting to $6,000,000.00.View SEC Filing
  • On 5/23/2014 Andrew N Schiff, Director, bought 1,333,333 with an average share price of $6.00 per share and the total transaction amounting to $7,999,998.00.View SEC Filing
  • On 5/29/2014 Care Capital Iii Llc, Major Shareholder, bought 500,000 with an average share price of $6.00 per share and the total transaction amounting to $3,000,000.00.View SEC Filing
  • On 1/23/2015 Jay Moorin, Major Shareholder, bought 811,966 with an average share price of $5.85 per share and the total transaction amounting to $4,750,001.10.View SEC Filing
  • On 6/2/2015 Alfred Altomari, CEO, bought 2,500 with an average share price of $8.73 per share and the total transaction amounting to $21,825.00.View SEC Filing
  • On 1/27/2016 Jay Moorin, Major Shareholder, bought 393,700 with an average share price of $6.35 per share and the total transaction amounting to $2,499,995.00.View SEC Filing
  • On 5/11/2017 Renee Selman, Insider, bought 53,333 with an average share price of $3.68 per share and the total transaction amounting to $196,265.44.View SEC Filing

    • Analyst Ratings For Agile Therapeutics, Inc. (NASDAQ:AGRX)
    These are 6 Buy Ratings .
    The current consensus rating for Agile Therapeutics, Inc. (NASDAQ:AGRX) is Buy (Score: 3.00) with a consensus target price of $10.00 , a potential (206.75% upside)

    Analyst Ratings History For Agile Therapeutics, Inc. (NASDAQ:AGRX)

    • On 11/10/2015 William Blair Reiterated Rating Buy with a price target of $18.00
    • On 3/11/2017 FBR & Co Set Price Target of rating Buy with a price target of $10.00
    • On 5/8/2017 Cantor Fitzgerald Reiterated Rating Buy with a price target of $9.00
    • On 7/16/2017 Royal Bank Of Canada Set Price Target of rating Buy with a price target of $8.00
    • On 7/19/2017 HC Wainwright Initiated Coverage of rating Buy to Buy with a price target of $10.00
    • On 7/30/2017 Noble Financial Reiterated Rating Buy
    • On 8/24/2017 Janney Montgomery Scott Reiterated Rating Buy with a price target of $15.00 to $13.00

    Recent Trading Activity for Agile Therapeutics, Inc. (NASDAQ:AGRX)
    Shares of Agile Therapeutics, Inc. closed the previous trading session at 3.26 down -0.07 -2.10% with 149,689 shares trading hands.